Early and reliable screening for Parkinson’s disease (PD) remains challenging, particularly when distinguishing PD from other movement disorders with overlapping motor manifestations. This study compares two three-class wearable-based screening frameworks using the PADS dataset, comprising 469 participants and 5159 smartwatch measurement sessions. The first framework uses a CNN–demographic network to extract 128-dimensional embeddings from motion signals and demographic variables, followed by gradient-boosting classification. The second uses 150 physics-informed handcrafted features spanning time-domain, frequency-domain, tremor-specific, and multiscale wavelet descriptors, classified by a soft-voting XGBoost–LightGBM ensemble. Both frameworks were evaluated using five-fold patient-disjoint cross-validation with dataset-wide out-of-fold predictions. The handcrafted ensemble achieved 72.28 % ± 3.19 % patient-level accuracy, a macro F1-score of 0.662 ± 0.037, and a pooled macro ROC-AUC of 0.825. The final no-attention deep pipeline achieved 68.9 % ± 4.6 % accuracy, a macro F1-score of 0.618 ± 0.042, and a macro ROC-AUC of 0.799. Although the handcrafted framework produced numerically higher results, paired patient-level tests showed no statistically significant differences between the two pipelines. Ablation analysis indicated that frequency-domain features provided the largest unique contribution to the handcrafted model, while demographic fusion was the most influential component of the deep architecture and attention provided no consistent benefit. Out-of-fold SHAP and failure-case analyses showed that errors were concentrated at the PD–other movement disorder boundary, including both borderline and high-confidence misclassifications. These findings support smartwatch-based three-class screening and decision support, while highlighting the limitations of single-modality wrist-motion data for reliable differential diagnosis. External multimodal validation is required before the framework can support clinical deployment.
No takes yet. Share an insight, caveat, or question.
Zeebaree et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: